The table below shows UNITED THERAPEUTICS Corp's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
-
-
$1.48B
Cost of revenue
$384.40M
$309.70M
$257.50M
$151.60M
$122.50M
$108.10M
Gross profit
$2.80B
$2.57B
$2.07B
$1.78B
$1.56B
$1.38B
R&D
$550.00M
$481.00M
$408.00M
$322.90M
$540.10M
$357.70M
SG&A
UTHR annual revenue (10-K history)
UNITED THERAPEUTICS Corp reported annual revenue of $3.18B for fiscal year 2025. That is up 10.6% from $2.88B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.60B (FY 2016) to $3.18B. Figures come from the company's audited annual reports as filed with the SEC.